Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jochen Rutz
HDAC Inhibition as a Treatment Concept to Combat Temsirolimus-Resistant Bladder Cancer Cells
Oncotarget
Oncology
mTOR Inhibition Reduces Growth and Adhesion of Hepatocellular Carcinoma Cells In�vitro
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Related publications
Inhibition of mTOR by Temsirolimus Contributes to Prolonged Survival of Mice With Pleural Dissemination of Non-Small-Cell Lung Cancer Cells
Cancer Science
Cancer Research
Medicine
Oncology
Differential Response of Cancer Cells to HDAC Inhibitors Trichostatin a and Depsipeptide
British Journal of Cancer
Cancer Research
Oncology
Targeting Dendritic Cells as a Good Alternative to Combat Leishmania Spp.
Frontiers in Immunology
Allergy
Immunology
Knockdown of MTDH Increases Drug Sensitivity to HDAC Inhibitor and TRAIL Combination Treatment in Endometrial Cancer Cells
Proceedings in Obstetrics and Gynecology
New and Emerging HDAC Inhibitors for Cancer Treatment
Journal of Clinical Investigation
Medicine
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
TYRO3 as a Molecular Target for Growth Inhibition and Apoptosis Induction in Bladder Cancer
British Journal of Cancer
Cancer Research
Oncology
EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer
Urology
Urology
PPARγ Inhibition Regulates the Cell Cycle, Proliferation and Motility of Bladder Cancer Cells
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology